C
7.48
-0.09 (-1.19%)
| Penutupan Terdahulu | 7.57 |
| Buka | 7.58 |
| Jumlah Dagangan | 866,663 |
| Purata Dagangan (3B) | 1,427,637 |
| Modal Pasaran | 591,296,960 |
| Harga / Pendapatan (P/E TTM) | 3.67 |
| Harga / Pendapatan (P/E Ke hadapan) | 11.78 |
| Harga / Jualan (P/S) | 1.91 |
| Harga / Buku (P/B) | 1.45 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2026 |
| Margin Keuntungan | 20.81% |
| Margin Operasi (TTM) | 51.49% |
| EPS Cair (TTM) | 0.250 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.41% |
| Nisbah Semasa (MRQ) | 4.21 |
| Aliran Tunai Operasi (OCF TTM) | -13.57 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -21.07 M |
| Pulangan Atas Aset (ROA TTM) | 8.31% |
| Pulangan Atas Ekuiti (ROE TTM) | 19.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | CorMedix Inc. | Menurun | Bercampur |
AISkor Stockmoo
1.4
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.38 |
|
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company’s focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.08% |
| % Dimiliki oleh Institusi | 34.20% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 14.00 (Needham, 87.17%) | Beli |
| 14.00 (D. Boral Capital, 87.17%) | Beli | |
| Median | 14.00 (87.17%) | |
| Purata | 14.00 (87.17%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 6.87 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Needham | 05 Mar 2026 | 14.00 (87.17%) | Beli | 6.30 |
| D. Boral Capital | 11 Feb 2026 | 14.00 (87.17%) | Beli | 7.43 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |